We are live on ! Find out more
ACH

ArrowMark Colorado Holdings Portfolio holdings

AUM $3.76B
1-Year Est. Return 21.77%
This Fund
S&P 500
This Quarter Est. Return
+5.85%
1 Year Est. Return
+21.77%
3 Year Est. Return
+58.74%
5 Year Est. Return
+55.15%
10 Year Est. Return
+474.07%
AUM
$372M
AUM Growth
–
Cap. Flow
+$366M
Cap. Flow %
98.47%
Top 10 Hldgs %
42.39%
Holding
134
New
131
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$37.8M
2
GLD icon
SPDR Gold Trust
GLD
+$27.4M
3
JPM icon
JPMorgan Chase
JPM
+$20.4M
4
MET icon
MetLife
MET
+$16.7M
5
XOM icon
ExxonMobil
XOM
+$12.2M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 28.54%
2 Energy 13.83%
3 Healthcare 9.26%
4 Real Estate 8.89%
5 Technology 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
76
Microsoft
MSFT
$3.66T
$669K 0.18%
+19,360
New +$634K
SIRO
77
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
$659K 0.18%
+10,000
New +$705K
GEVA
78
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$651K 0.18%
+15,500
New +$706K
COO icon
79
Cooper Companies
COO
$14.6B
$625K 0.17%
+21,016
New +$591K
ILMN icon
80
Illumina
ILMN
$30.7B
$613K 0.16%
+8,423
New +$539K
PBYI icon
81
Puma Biotechnology
PBYI
$397M
$565K 0.15%
+12,723
New +$449K
HCA icon
82
HCA Healthcare
HCA
$86.8B
$541K 0.15%
+15,000
New +$580K
MRO
83
PUT
DELISTED
Marathon Oil Corporation
MRO
$519K 0.14%
+15,000
New +$507K
CL icon
84
Colgate-Palmolive
CL
$73.8B
$458K 0.12%
+8,000
New +$475K
OXY icon
85
Occidental Petroleum
OXY
$54.8B
$443K 0.12%
+5,188
New +$438K
ACAD icon
86
Acadia Pharmaceuticals
ACAD
$4.65B
$430K 0.12%
+23,702
New +$326K
INFI
87
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$403K 0.11%
+24,894
New +$770K
KSU
88
DELISTED
Kansas City Southern
KSU
$395K 0.11%
+3,732
New +$406K
BMY icon
89
CALL
Bristol-Myers Squibb
BMY
$135B
$380K 0.1%
+8,500
New +$369K
PCYC
90
DELISTED
PHARMACYCLICS INC
PCYC
$380K 0.1%
+4,784
New +$391K
SHPG
91
CALL
DELISTED
Shire pic
SHPG
$361K 0.1%
+3,800
New +$356K
TEVA icon
92
CALL
Teva Pharmaceuticals
TEVA
$40.1B
$352K 0.09%
+9,000
New +$350K
MDT icon
93
CALL
Medtronic
MDT
$110B
$345K 0.09%
+6,700
New +$331K
BIIB icon
94
CALL
Biogen
BIIB
$30.8B
$344K 0.09%
+1,600
New +$342K
FRX
95
CALL
DELISTED
FOREST LABORATORIES INC
FRX
$341K 0.09%
+8,300
New +$321K
CBST
96
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$328K 0.09%
+6,786
New +$334K
VRTX icon
97
CALL
Vertex Pharmaceuticals
VRTX
$121B
$320K 0.09%
+4,000
New +$295K
STJ
98
CALL
DELISTED
St Jude Medical
STJ
$320K 0.09%
+7,000
New +$303K
BIIB icon
99
Biogen
BIIB
$30.8B
$312K 0.08%
+1,450
New +$310K
GE icon
100
GE Aerospace
GE
$391B
$306K 0.08%
+2,754
New +$305K
2 3
4
5 6

Similar funds

SCA
Snowden Capital Advisors New York $3.76B AUM 23.4% 1-Year Est. Return
VA
VestGen Advisors Inverness, Illinois $3.76B AUM 26.04% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
VVP
Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return
GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return

ArrowMark Colorado Holdings's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for ArrowMark Colorado Holdings, which disclosed 134 positions worth $372M. Its ten largest holdings account for 42% of the portfolio.

Its largest position is Citigroup: 785,556 shares worth $37.7M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, followed by Energy and Healthcare.

  • ArrowMark Colorado Holdings's largest Q2 2013 buy was Citigroup: 785,556 shares worth $37.7M.
  • ArrowMark Colorado Holdings's ten largest holdings make up 42% of its $372M portfolio in Q2 2013.
  • ArrowMark Colorado Holdings disclosed 134 positions in Q2 2013, its first 13F filing on record.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2013, filed 14 Aug 2013.